Some studies have shown that serum levels of matrix metalloproteinase‐9 (MMP‐9), cellular fibronectin, and occludin can predict s‐HT in patients with ischemic stroke [8, 9, 10, 11, 12]. This evidence concerns the gene OCLN and ischemic stroke.